Chemical formula: C₂₄H₂₀Cl₂N₂OS Molecular mass: 455.4 g/mol
Fenticonazole is a broad-spectrum antimycotic agent.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D01AC12 | Fenticonazole | D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives |
| G01AF12 | Fenticonazole | G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| GYNOXIN Vaginal capsule, soft | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| GYNOXIN Vaginal cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Fenticonazole is an active ingredient of these brands:
Austria (AT)
Brazil (BR)Croatia (HR)
Cyprus (CY)
Ecuador (EC)
Estonia (EE)
France (FR)
Hong Kong (HK)
Lithuania (LT)
Mexico (MX)
Poland (PL)
Romania (RO)
South Africa (ZA)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
